Pennsylvania Senate Targets Hemp THC Products in Amended Cannabis Bill

Pennsylvania lawmakers have added sweeping restrictions on hemp-derived THC products to a cannabis regulation bill, moving to shut down a legal gray area that's allowed delta-8 THC and similar compounds to flourish in smoke shops and convenience stores across the state.

The Senate Law and Justice Committee amended the legislation this week to ban most intoxicating hemp products—a shift that comes as the Drug Enforcement Administration prepares to implement new federal rules in November that would reclassify many of these products as controlled substances.

The amendment represents a significant pivot for the bill, which initially focused on establishing a regulatory framework for adult-use cannabis. But with marijuana legalization efforts stalled in Pennsylvania's legislature, the hemp crackdown has emerged as the more immediate priority.

The Hemp Loophole

Hemp-derived THC products have existed in a regulatory gray zone since the 2018 Farm Bill federally legalized hemp containing less than 0.3% delta-9 THC. Manufacturers quickly exploited this framework by extracting other THC isomers—like delta-8, delta-10, and THC-O—from legal hemp and selling them as unregulated alternatives to marijuana.

The result has been a booming market for products that produce psychoactive effects similar to traditional cannabis, available without the licensing requirements or testing standards that govern state marijuana programs. Industry estimates suggest the hemp-derived cannabinoid market has grown to over $2 billion nationally.

Pennsylvania's amendment would effectively end that market in the state. The new language prohibits the sale of hemp products containing "total THC" above the 0.3% threshold, closing the loophole that allowed delta-8 and related compounds.

Industry Response

The move has created strange bedfellows. Licensed medical marijuana operators have long complained that unregulated hemp products undercut their heavily taxed and tested offerings. Yet some hemp businesses that invested in Pennsylvania operations now face potential shutdowns.

Small retailers who've stocked hemp THC products alongside CBD oils and wellness items could see a major revenue stream disappear. These businesses have operated under the assumption that federal hemp legalization meant their products were legal—an assumption the DEA's forthcoming rule change has now challenged.

What's Next

The amended bill still needs to clear the full Senate before moving to the House, where adult-use cannabis legalization has faced consistent opposition despite public polling showing majority support among Pennsylvania voters.

The November timeline looms large. The DEA's interim final rule on hemp-derived cannabinoids is scheduled to take effect then, creating federal-level restrictions that Pennsylvania lawmakers appear eager to match at the state level.

For now, the amendment signals that Pennsylvania may regulate hemp THC products before it regulates recreational marijuana—an ironic outcome in a state where legalization advocates have pushed for comprehensive reform for years. The Senate committee's action suggests lawmakers view hemp product restrictions as more politically palatable than full cannabis legalization, even as neighboring states like New Jersey and New York have already launched adult-use markets.

The bill's fate in the full legislature remains uncertain, but the hemp provisions have added new urgency to debates that have dragged on without resolution.

This article is based on original reporting by www.marijuanamoment.net.